AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Claudio Dansky Ullmann'
:
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. Publication Year: 2009
DOI: https://doi.org/10.1002/hed.21269
Abstract:
Add to Library
Authors:
David J. Adelstein
John A. Ridge
Maura L. Gillison
Anil K. Chaturvedi
Gypsyamber D’Souza
Patti E. Gravitt
William H. Westra
Amanda Psyrri
W. Martin Kast
Laura A. Koutsky
Anna R. Giuliano
Steven H. Krosnick
Andy Trotti
David E. Schuller
Arlene A. Forastiere
Claudio Dansky Ullmann
Abstract B070: IPI-549-01: A Phase I/Ib first in human study of IPI-549, a PI3K-γ inhibitor, as monotherapy and in combination with an anti-PD-1 antibody in subjects with advanced solid tumors Publication Year: 2016
DOI: https://doi.org/10.1158/2326-6066.imm2016-b070
Abstract:
Add to Library
Authors:
Anthony W. Tolcher
David S. Hong
Ryan J. Sullivan
James W. Mier
Geoffrey I. Shapiro
Joseph Pearlberg
Les Brail
Jahnavi Kharidia
Lixin Han
Claudio Dansky Ullmann
Howard M. Stern
Jedd D. Wolchok
Abstract CT159: A phase 1 study of intraperitoneal MCY-M11 therapy for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy Publication Year: 2019
DOI: https://doi.org/10.1158/1538-7445.am2019-ct159
Abstract:
Add to Library
Authors:
Armin Ghobadi
Premal H. Thaker
David Weng
Julie Vanas
Irene Ekwede
M. Yu Pavlova
Robert Keefe
Michael Kuo
Claudio Dansky Ullmann
Raffit Hassan
Christina M. Annunziata
OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC) Publication Year: 2017
DOI: https://doi.org/10.1016/j.jtho.2016.11.253
Abstract:
Add to Library
Authors:
Taofeek K. Owonikoko
Kristiaan Nackaerts
Tibor Csöszi
Gyula Ostoros
Christina Baik
Claudio Dansky Ullmann
Erin Zagadailov
Emily Sheldon‐Waniga
Dirk Huebner
E. Jane Leonard
David R. Spigel
Abstract CT089: IPI-549-01 - A Phase 1/1b, first-in-human study of IPI-549, a PI3K-γ inhibitor, as monotherapy and in combination with nivolumab in patients with advanced solid tumors Publication Year: 2017
DOI: https://doi.org/10.1158/1538-7445.am2017-ct089
Abstract:
Add to Library
Authors:
Anthony W. Tolcher
David S. Hong
Ryan J. Sullivan
James W. Mier
Geoffrey I. Shapiro
Bartosz Chmielowski
Antoni Ribas
Michael A. Postow
Joseph Pearlberg
Les Brail
Lucy Lee
Claudio A. Dansky Ullmann
Jedd D. Wolchok
Human Papillomavirus and Oral Cancer: Looking Toward the Clinic Publication Year: 2008
DOI: https://doi.org/10.1093/jnci/djn198
Abstract:
Add to Library
Authors:
Negative Data From Lung Cancer Trial May Change Practice Guidelines, Study Designs Publication Year: 2006
DOI: https://doi.org/10.1093/jnci/djj459
Abstract:
Add to Library
Authors:
Erratum to: Translating genomics into clinical practice: applications in lung cancer Publication Year: 2009
DOI: https://doi.org/10.1007/s11912-009-0069-4
Abstract:
Add to Library
Authors:
Claudio Danky Ullmann
Llisa McShane
32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Late-Breaking Abstracts Publication Year: 2017
DOI: https://doi.org/10.1186/s40425-017-0297-3
Abstract:
Add to Library
Authors:
OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC) Publication Year: 2017
DOI: https://doi.org/10.1016/j.jtho.2016.11.252
Abstract:
Add to Library
Authors:
David R. Spigel
M. Catherine Pietanza
Todd M. Bauer
Neal Ready
Daniel Morgensztern
Bonnie S. Glisson
Lauren A. Byers
Melissa L. Johnson
Howard A. Burris
Francisco Robert
Tae Hyung Han
Sheila Bheddah
Noah Theiss
Sky Watson
Deepan Mathur
Bharathi Vennapusa
Donald K. Strickland
Hany Zayed
Scott J. Dylla
Stanford L. Peng
Ramaswamy Govindan
Charles M. Rudin
Abstract CT159: A phase 1 study of intraperitoneal MCY-M11 therapy for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy Publication Year: 2019
DOI: https://doi.org/10.1158/1538-7445.sabcs18-ct159
Abstract:
Add to Library
Authors:
Armin Ghobadi
Premal H. Thaker
David Weng
Julie Vanas
Irene Ekwede
M. Yu Pavlova
Robert Keefe
Michael Kuo
Claudio Dansky Ullmann
Raffit Hassan
Christina M. Annunziata
IMPROVED IMMUNOTHERAPEUTIC EFFICACY OF AN ANTI-CARCINOMA MONOCLONAL ANTIBODY (CC49) WHEN GIVEN IN COMBINATION WITH IFN-γ Publication Year: 1993
DOI: https://doi.org/10.1097/00002371-199301000-00044
Abstract:
Add to Library
Authors:
Carol Nieroda
Claudio Dansky-Ullmann
Chen‐Feng Qi
Shinya Shimada
Jeffrey Schlom
John W. Greiner
Abstract CT122: A phase 1/2 open-label, multicenter, dose escalation and expansion study of AVB-001, an intraperitoneally administered, cell-generated, human IL-2 immunotherapy in patients with platinum-resistant, high-grade, serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.am2023-ct122
Abstract:
Add to Library
Authors:
Shannon N. Westin
Travis T. Sims
Karen Andreas
Eric Soliman
Manish Jain
Claudio A. Dansky Ullmann
Amir A. Jazaeri
Found 13 results in 0.092 seconds
What is Boolean Searches
Including any of the words AND, OR, or NOT in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *, ? or ~ are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo" and "sesame street", but not the words
"cookie" or "monster":
"elmo" AND "sesame street" NOT "cookie" NOT "monster"